SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 1233-1241.
  • 2
    Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: 6 years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr. 1992;( 11): 19-25.
  • 3
    Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer. 2003; 98: 697-702.
  • 4
    van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000; 92: 1143-1150.
  • 5
    Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 1227-1232.
  • 6
    START Trialists Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet. 2008; 371: 1098-1107.
  • 7
    Whelan T, Pignol J, Levine M, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010; 362: 513-520.
  • 8
    Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000; 92: 269-271.
  • 9
    Lazovich DA, White E, Thomas DB, Moe RE. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA. 1991; 266: 3433-3438.
  • 10
    Schroen AT, Brenin DR, Kelly MD, Knaus WA, Slingluff CLJr. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol. 2005; 23: 7074-7080.
  • 11
    Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003; 95: 1205-1210.
  • 12
    Chen PY, Vicini FA, Benitez P, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer. 2006; 106: 991-999.
  • 13
    Chen PY, Wallace M, Mitchell C, et al. Four-year efficacy, cosmesis, and toxicity using 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010; 76: 991-997.
  • 14
    Vicini FA, Chen P, Wallace M, et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2007; 69: 1124-1130.
  • 15
    Goyal S, Khan AJ, Vicini F, et al. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial. Ann Surg Oncol. 2009; 16: 2450-2458.
  • 16
    Khan AJ, Vicini F, Beitsch P, et al. Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial. Ann Surg Oncol. 2009; 16: 1612-1618.
  • 17
    Arthur DW, Vicini FA. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol. 2005; 23: 1726-1735.
  • 18
    Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010; 376: 91-102.
  • 19
    Reitsamer R, Fastner G, Kopp M, Menzel C, Sedlmayer F. Intraoperative radiotherapy for early breast cancer. Lancet. 2010; 376: 1141; author reply 1143-1144.
  • 20
    Smith BD, Buchholz TA, Kuerer HM. Intraoperative radiotherapy for early breast cancer. Lancet. 2010; 376: 1141; author reply 1143-1144.
  • 21
    Haviland JS, A'Hern R, Bliss JM. Intraoperative radiotherapy for early breast cancer. Lancet. 2010; 376: 1142; author reply 1143-1144.
  • 22
    Cameron D, Kunkler I, Dixon M, Jack W, Thomas J, Kerr G. Intraoperative radiotherapy for early breast cancer. Lancet. 2010; 376: 1142; author reply 1143-1144.
  • 23
    Azria D, Bourgier C. Partial breast irradiation: new standard for selected patients. Lancet. 2010; 376: 71-72.
  • 24
    Sautter-Bihl ML, Sedlmayer F, Budach W, et al. Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer: beware of 1-stop shops? Strahlenther Onkol. 2010; 186: 651-657.
  • 25
    Veronesi U, Gatti G, Luini A, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg. 2003; 138: 1253-1256.
  • 26
    Veronesi U, Orecchia R, Luini A, et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat. 2010; 124: 141-151.
  • 27
    Orecchia R, Ciocca M, Lazzari R, et al. Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast. 2003; 12: 483-490.
  • 28
    Beal K, McCormick B, Zelefsky MJ, et al. Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results. Int J Radiat Oncol Biol Phys. 2007; 69: 19-24.
  • 29
    Wallace M, Martinez A, Mitchell C, et al. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule. Int J Radiat Oncol Biol Phys. 2010; 77: 531-536.
  • 30
    Sacchini V, Beal K, Goldberg J, Montgomery L, Port E, McCormick B. Study of quadrant high-dose intraoperative radiation therapy for early-stage breast cancer. Br J Surg. 2008; 95: 1105-1110.
  • 31
    Rosenstein B, Lymberis S, Formenti S. Biologic comparison of partial breast irradiation protocols. Int J Radiat Oncol Biol Phys. 2004; 60: 1393-1404.
  • 32
    Cohen L. Radiotherapy in breast cancer. The dose-time relationship: theoretical considerations. Br J Radiol. 1952; 25: 636-642.
  • 33
    Fowler J. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989; 62: 679-694.
  • 34
    Owen J, Ashton A, Bliss J, et al. Effect of radiotherapy fraction size on tumor control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 2006; 7: 467-471.
  • 35
    Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol. 2005; 75: 9-17.
  • 36
    Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008; 9: 331-341.
  • 37
    Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008; 371: 1098-1107.
  • 38
    Cuttino LW, Todor D, Pacyna L, Lin PS, Arthur DW. Three-dimensional conformal external beam radiotherapy (3D-CRT) for accelerated partial breast irradiation (APBI): what is the correct prescription dose? Am J Clin Oncol. 2006; 29: 474-478.
  • 39
    Vaidya JS, Tobias JS, Baum M, et al. TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol. 2005; 15: 84-91.
  • 40
    Vaidya JS, Tobias JS, Baum M, et al. Intraoperative radiotherapy for breast cancer. Lancet Oncol. 2004; 5: 165-173.
  • 41
    Clark RM, McCulloch PB, Levine MN, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992; 84: 683-689.
  • 42
    Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993; 328: 1587-1591.
  • 43
    Belletti B, Vaidya JS, D'Andrea S, et al. Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res. 2008; 14: 1325-1332.
  • 44
    Vaidya JS, Baum M, Tobias JS, et al. Long-term results of targeted intraoperative radiotherapy (TARGIT) boost during breast-conserving surgery. Int J Radiat Oncol Biol Phys. [published online ahead of print October 15, 2010.]
  • 45
    Vaidya JS. Intraoperative radiotherapy for early stage breast cancer. Authors' reply. Lancet. 2010; 376: 1143-1144.
  • 46
    Vaidya JS, Tobias J, Baum M, et al. Intraoperative radiotherapy: the debate continues. Lancet Oncol. 2004; 5: 339-340.
  • 47
    Enderling H, Anderson AR, Chaplain MA, Munro AJ, Vaidya JS. Mathematical modelling of radiotherapy strategies for early breast cancer. J Theor Biol. 2006; 241: 158-171.
  • 48
    Enderling H, Chaplain MA, Anderson AR, Vaidya JS. A mathematical model of breast cancer development, local treatment and recurrence. J Theor Biol. 2007; 246: 245-259.
  • 49
    Kim MY, Oskarsson T, Acharyya S, et al. Tumor self-seeding by circulating cancer cells. Cell. 2009; 139: 1315-1326.
  • 50
    Anscher MS, Jones P, Prosnitz LR, et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg. 1993; 218: 22-28.
  • 51
    Borger JH. The impact of surgical and pathological findings on radiotherapy of early breast cancer. Radiother Oncol. 1991; 22: 230-236.
  • 52
    Cabioglu N, Hunt KK, Buchholz TA, et al. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer. 2005; 104: 20-29.
  • 53
    Dewar JA, Arriagada R, Benhamou S, et al. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer Group. Cancer. 1995; 76: 2260-2265.
  • 54
    Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys. 1999; 44: 1005-1015.
  • 55
    Obedian E, Haffty BG. Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am. 2000; 6: 28-33.
  • 56
    Peterson ME, Schultz DJ, Reynolds C, Solin LJ. Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 1999; 43: 1029-1035.
  • 57
    Wazer DE, Jabro G, Ruthazer R, Schmid C, Safaii H, Schmidt-Ullrich RK. Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation. Radiat Oncol Investig. 1999; 7: 111-117.
  • 58
    Vicini FA, Goldstein NS, Pass H, Kestin LL. Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2004; 60: 86-94.
  • 59
    Gujral DM, Sumo G, Owen JR, et al. Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries. Int J Radiat Oncol Biol Phys. 2011; 79: 19-25.
  • 60
    McGrath S, Antonucci J, Goldstein N, et al. Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: a molecular based clonality evaluation. Am J Clin Oncol. 2010; 33: 17-22.
  • 61
    Goldstein NS, Vicini FA, Hunter S, Odish E, Forbes S, Kestin LL. Molecular clonality relationships in initial carcinomas, ipsilateral breast failures, and distant metastases in patients treated with breast-conserving therapy: evidence suggesting that some distant metastases are derived from ipsilateral breast failures and that metastases can metastasize. Am J Clin Pathol. 2005; 124: 49-57.
  • 62
    Goldstein NS, Vicini FA, Hunter S, et al. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors. Am J Clin Pathol. 2005; 123: 679-689.
  • 63
    Vicini FA, Antonucci JV, Goldstein N, et al. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy. Cancer. 2007; 109: 1264-1272.
  • 64
    Goldstein NS, Kestin LJ, Vicini FA. Monomorphic epithelial proliferations: characterization and evidence suggesting they are the pool of partially transformed lesions from which some invasive carcinomas arise. Am J Clin Pathol. 2007; 128: 1023-1034.
  • 65
    Orecchia R, Veronesi U. Intraoperative electrons. Semin Radiat Oncol. 2005; 15: 76-83.
  • 66
    Luini A, Orecchia R, Gatti G, et al. The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treatment. 2005; 93: 55-59.
  • 67
    Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys. 2004; 60: 722-730.
  • 68
    Lemanski C, Azria D, Gourgon-Bourgade S, et al. Intraoperative radiotherapy in early-stage breast cancer: results of the Montpellier phase II trial. Int J Radiat Oncol Biol Phys. 2010; 76: 698-703.
  • 69
    Wyatt R, Jones B, Dale R. Radiotherapy treatment delays and their influence on tumour control achieved by various fractionation schedules. Br J Radiol. 2008; 81: 549-563.
  • 70
    Dale R, Coles I, Deehan C, O'Donoghue J. Calculation of integrated biological response in brachytherapy. Int J Radiat Oncol Biol Phys. 1997; 38: 633-642.
  • 71
    Grills I, Martinez A, Hollander M, et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared with low dose rate palladium seeds. J Urol. 2004; 171: 1098-1104.